The failure of C.R Bard to discuss known risks and potential complications that would result from the use of its transvaginal mesh product with patients has placed the company under fire for litigation. Transvaginal mesh is used to correct a condition called pelvic organ prolapse, which often occurs after women have given birth and causes the muscles and organs in the pelvic area to be pushed out of place. In the past, this condition has been treated with traditional surgery and transvaginal mesh products have been offered as a less invasive alternative. Unfortunately, these products have caused severe medical issues and C.R Bard is among the companies being held liable for products that have been deemed unfit for medical use.
Complications Due to Avaulta Mesh
The Bard Avaulta Anterior and Posterior Biosynthetic Support System is commonly referred to simply as the Bard Avaulta mesh and was designed to act as a sling, holding the tissues and organs that have shifted back in place. Transvaginal mesh has been associated with numerous complications, however, which include internal bleeding, infections, harm to muscles, organs or tissue and a perforated bowel, bladder or urethra. These complications have the potential to be life threatening or contribute to life threatening conditions.
Additional Surgery Necessary To Remedy Complications
While the selling point of transvaginal mesh products has been to minimize the invasiveness of surgeries, the resulting complications require one or more surgeries to address. Perforation of the bowel, bladder or urethra is a serious condition that may cause sepsis if left untreated. Treatment for these issues is expensive and recovery is often painful. In addition to the pain and suffering, many women are left feeling shame because of the injury done to the most private area of their bodies.
C.R Bard’s Knowledge of Complications
Evidence has surfaced that C.R Bard was aware of the potential risks associated with their products and that these risks were hidden from prospective patients. Some of the materials used in the production of its Avaulta mesh has been deemed unfit for human use and is thought to be the cause of the complications. Due to C.R Bard’s prior knowledge of these issues and its failure to address them, C.R Bard may be held liable for the financial cost and pain and suffering endured by its victims.
Our Commitment To Your Success
If you have suffered undue injury because of the Bard Avaulta mesh, Rosenfeld Injury Lawyers are here to help you recover your financial losses and your dignity. We will work tirelessly to help you on the road to recovery without an undue financial burden due to the cost of your medical care. Our access to experts in the field of medicine allows us to be able to accurately assign a value to your case in order to ensure that we collect every bit of compensation that you are entitled to.
Contact us today to begin the process with a free consultation. We will answer all of your questions and explain your rights as well as the legal process and the next steps to take on the path to winning your case.